Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Behavioural Brain Research|May 29, 2020
Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketaminePradeep Banerjee, John E Donello, Brendan Hare, et al.
Molecular and Cellular Biology|March 9, 2002
CRM1-dependent function of a cis-acting RNA export elementIleana Popa, Matthew E Harris, John E Donello, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA ReceptorJohn E Donello, Roger S McIntyre, Donald B Pickel, et al.
The International Journal of Neuropsychopharmacology|July 26, 2022
Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like EffectsJeffrey S Burgdorf, Xiao-Lei Zhang, Patric K Stanton, et al.
Neuropharmacology|February 24, 2024
The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorderMathieu Fonteneau, Agathe Brugoux, Déborah Jaccaz, et al.
The International Journal of Neuropsychopharmacology|December 14, 2018
Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like EffectsJohn E Donello, Pradeep Banerjee, Yong-Xin Li, et al.
Pageof 2